UCC’s Clisteprobe diagnostic technology aims to reduce anxiety...
The new venture from UCC and Tyndall National Institute was funded by an Enterprise Ireland (EI) Commercialisation Fund to develop a bioimpedance biopsy needle.
Clisteprobe specialises in developing advanced biopsy devices which will improve the accuracy and efficiency of disease detection in breast cancer...
Read more